hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells

Molecular Cancer Therapeutics

Volumn 7, Issue 9, 2008, Pages 2798-2806

  Wang, Xuening ^a   Patel, Rahul ^a   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCIFEDIOL; CASPASE 3; CYTARABINE TRIPHOSPHATE; KINASE SUPPRESSOR OF RAS 1; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN MCL 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; UPREGULATION;

ACETYLCYSTEINE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIOXIDANTS; APOPTOSIS; CYTARABINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; NECROSIS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, SMALL INTERFERING; VITAMIN D;

EID: 54049106186     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0276     Document Type: Article

References (45)

1. de las Heras B, Hortelano S, Giron N, Bermejo P, Rodriguez B, Bosca L. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages. Br J Pharmacol 2007;152:249-55.
2. Huang XJ, Wiernik PH, Klein RS, Gallagher RE. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Med Oncol 1999;16:58-64.
3. 3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes. Leukemia 1994;8:806-15.
4. Castaigne S, Chomienne C, Daniel MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990;76:1704-9.
5. Koeffler HP. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 1983;62:709-21.
6. Studzinski GP, Wang X, Ji Y, et al. The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway. J Steroid Biochem Mol Biol 2005;97:47-55.
7. 3. Proc Natl Acad Sci U S A 1981;78:4990-4.
8. 3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res 1997;235:210-7.
9. Wang HG, Miyashita T, Takayama S, et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 1994;9:2751-6.
10. Weissinger EM, Eissner G, Grammer C, et al. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. Mol Cell Biol 1997;17:3229-41.
11. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-31.
12. Stadheim TA, Xiao H, Eastman A. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. Cancer Res 2001;61:1533-40.
13. 3-induced differentiation of HL60 cells. J Cell Biochem 2001;80:471-82.
14. Marcinkowska E. Evidence that activation of MEK1,2/ERK1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells. Anticancer Res 2001;21:499-504.
15. 3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module. J Cell Physiol 2006;209:253-60.
16. 3. J Cell Physiol 2004;198:333-42.
17. 3 in human leukemia HL60 cells through a vitamin D response element in the 5′-flanking region. Oncogene 2006;25:7078-85.
18. Ohmachi M, Rocheleau CE, Church D, Lambie E, Schedl T, Sundaram MV. C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation. Curr Biol 2002;12:427-33.
19. Channavajhala PL, Wu L, Cuozzo JW, et al. Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling. J Biol Chem 2003;278:47089-97.
20. Wang X, Wang TT, White JH, Studzinski GP. Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation. Exp Cell Res 2007;313:3034-45.
21. Baran CP, Zeigler MM, Tridandapani S, Marsh CB. The role of ROS and RNS in regulating Life and death of blood monocytes. Curr Pharm Des 2004;10:855-66.
22. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979;54:713-33.
23. Ramachandra S, Studzinski GP. Morphological and biochemical criteria of apoptosis (Chapter 7). In: Cell growth and apoptosis: a practical approach. Oxford (NY): IRL Press at the Oxford University Press; 1995.
24. McGahon AJ, Martin SJ, Bissonnette RP, et al. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol 1995;46:153-85.
25. Hu ZB, Yang GS, Li M, Miyamoto N, Minden MD, McCulloch EA. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Leukemia 1995;9:789-98.
26. Opferman JT, Iwasaki H, Ong CC, et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005;307:1101-4.
27. Yang T, Buchan HL, Townsend KJ, Craig RW. MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol 1996;166:523-36.
28. Channavajhala PL, Rao VR, Spaulding V, Lin LL, Zhang YG. hKSR-2 inhibits MEKK3-activated MAP kinase and NF-κB pathways in inflammation. Biochem Biophys Res Commun 2005;334:1214-8.
29. Yan F, John SK, Wilson G, Jones DS, Washington MK, Polk DB. Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J Clin Invest 2004;114:1272-80.
30. Szatmari E, Kalita KB, Kharebava G, Hetman M. Role of kinase suppressor of Ras-1 in neuronal survival signaling by extracellular signal-regulated kinase 1/2. J Neurosci 2007;27:11389-400.
31. Kim M, Yan Y, Kortum RL, et al. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity. Cancer Res 2005;65:3986-92.
32. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005;6:827-37.
33. Roy F, Laberge G, Douziech M, Ferland-McCollough D, Therrien M. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev 2002;16:427-38.
34. Ory S, Morrison DK. Signal transduction: implications for Ras-dependent ERK signaling. Curr Biol 2004;14:R277-8.
35. Therrien M, Chang HC, Solomon NM, Karim FD, Wassarman DA, Rubin GM. KSR, a novel protein kinase required for RAS signal transduction. Cell 1995;83:879-88.
36. Roy F, Therrien M. MAP kinase module: the Ksr connection. Curr Biol 2002;12:R325-7.
37. Michaud NR, Therrien M, Cacace A, et al. KSR stimulates Raf-1 activity in a kinase-independent manner. Proc Natl Acad Sci U S A 1997;94:12792-6.
38. Xing HR, Campodonico L, Kolesnick R. The kinase activity of kinase suppressor of Ras1 (KSR1) is independent of bound MEK. J Biol Chem 2004;279:26210-4.
39. Belkhiri A, Dar AA, Zaika A, Kelley M, El-Rifai W. t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism. Cancer Res 2008;68:395-403.
40. Decaudin D, Geley S, Hirsch T, et al. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 1997;57:62-7.
41. Avramis VI, Nandy P, Kwock R, et al. Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells. Anticancer Res 1998;18:2327-38.
42. Dasmahapatra G, Almenara JA, Grant S. Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2. Mol Pharmacol 2006;69:288-98.
43. Hedley DW, McCulloch EA. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2. Leukemia 1996;10:1143-9.
44. Kanno S, Higurashi A, Watanabe Y, Shouji A, Asou K, Ishikawa M. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines. Toxicol Lett 2004;152:149-58.
45. Deberardinis RJ, Mancuso A, Daikhin E, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 2007;104:19345-50.